Artios Announces ATR Inhibitor, ART0380, Development On Track and Progressing Into Phase 1b…
Phase 1a dose escalation of ART0380 defined initial regimen to be evaluated in Phase 1b setting.Phase 1a dose escalation demonstrated a predictable safety profile and no unexpected safety findings supported by data from over 35…